跳至主要内容
临床试验/EUCTR2008-003693-17-NL
EUCTR2008-003693-17-NL进行中(未招募)不适用

Treatment of Complex Regional Pain Syndrome type I: A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions - KetKetStudy

eiden University Medical Center0 个研究点目标入组 30 人开始时间: 2008年6月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients are diagnosed with CRPS-1 according to the IASP-criteria;
  • Patients must report a NRS spontaneous pain score of 5 or higher;
  • The age of the patient is between 18 and 70 years;
  • Patients must give a written informed consent;
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who are not able to give informed consent;
  • Patients suffering from other syndromes/diseases interfering with pain ratings;
  • Patients who have had previous ketamine continuous infusion;
  • Patients with co-morbidity such as: kidney disease, severe liver disease, nerve damage in the
  • affected area, increased intracranial pressure, infectious disease, epilepsy, a psychiatric
  • illness, thyroid disease, cancer, cardiac disease, pulmonary disease, severe or uncontrolled
  • hypertension, aneurysm, glaucoma, history of cerebral vascular accident (CVA) < 1 year;
  • Patients who are pregnant.

研究者

发起方
eiden University Medical Center

相似试验

Treatment of Complex Regional Pain Syndrome type I:... | 临床试验